Compare Stocks

→ Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABCN VIVO Cannabis	C$1.32 +5.6%	C$1.32	C$0.80 ▼ C$4.06	C$256.62M	N/A	1.51 million shs	310,601 shs
ATTBF Abattis Bioceuticals		$0.00	$0.00 ▼ $0.00	N/A	N/A	11,650 shs	25,300 shs
IPIX Innovation Pharmaceuticals	$0.00 -20.0%	$0.01	$0.00 ▼ $0.02	N/A	N/A	746,684 shs	190,500 shs

7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABCN VIVO Cannabis	0.00%	0.00%	0.00%	0.00%	0.00%
ATTBF Abattis Bioceuticals	0.00%	0.00%	0.00%	0.00%	0.00%
IPIX Innovation Pharmaceuticals	-28.57%	-75.00%	-82.76%	-74.49%	-87.11%

Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
IPIX Innovation Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A
IPIX Innovation Pharmaceuticals	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A	N/A
IPIX Innovation Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABCN VIVO Cannabis	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	-$0.16	N/A	N/A	N/A	N/A	N/A	N/A	N/A
IPIX Innovation Pharmaceuticals	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A
IPIX Innovation Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
ABCN VIVO Cannabis	N/A
ATTBF Abattis Bioceuticals	32.45%
IPIX Innovation Pharmaceuticals	N/A

Insider Ownership

Company	Insider Ownership
ABCN VIVO Cannabis	N/A
ATTBF Abattis Bioceuticals	N/A
IPIX Innovation Pharmaceuticals	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ABCN VIVO Cannabis	N/A	194.41 million	N/A	Not Optionable
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	Not Optionable
IPIX Innovation Pharmaceuticals	4	N/A	N/A	Not Optionable

IPIX, ATTBF, ABCN, ABZA, and AHZ Headlines

Source	Headline
	Tech-Driven Innovations Revolutionize Pharmaceutical Clinical Trials dailynewsen.com - April 23 at 1:46 PM
	Bios Health Group launches innovation circle to advance life sciences outsourcing-pharma.com - April 17 at 2:58 PM
	InnovationRx: $90 Million To Make Drugs In Space forbes.com - April 10 at 10:35 PM
	India's healthcare innovation market poised to double by 2028 msn.com - March 25 at 4:44 AM
	Pharma company Jubilant Biosys plans to expand India footprint, to foray into new therapeutic areas, says CEO Giuliano Perfetti msn.com - February 29 at 9:06 AM
	New Pharmpack Index Reports Highs in Drug Delivery Innovation healthcarepackaging.com - February 2 at 7:12 PM
	Healthcare & Pharma Outlook 2024: Companies to focus on quality, sustainability, and accessibility; Surge in R&D expected msn.com - January 4 at 4:34 PM
	3 Stocks at the Forefront of Medical Innovation msn.com - December 25 at 8:57 PM
	Patrick Couvreur: Inspiring Pharmaceutical Innovation medscape.com - December 23 at 11:14 AM
	Drug Delivery Innovation Index reveals surge in innovation medicalplasticsnews.com - December 21 at 7:06 AM
	Prof Paul Ross of UCC declared Ireland’s Researcher of the Year siliconrepublic.com - November 20 at 9:33 AM
	Innovation Pharmaceuticals Inc IPIX morningstar.com - November 14 at 3:46 AM
	Innovation Pharmaceuticals Inc IPIX morningstar.com - November 14 at 3:46 AM
	EU proposal may accelerate pharma innovation decline, industry group says msn.com - November 5 at 10:40 PM
	How CPI's latest project will help to digitally transform the pharma industry msn.com - October 27 at 9:52 AM
	Social media in Spain; core to pharmaceutical innovation? pharmaphorum.com - October 21 at 1:19 PM
	Pharma Industry Should Prioritise R&D, Focus On Innovative Products: Union Health Minister msn.com - September 26 at 8:24 AM
	Innovation Pharmaceuticals Announces New Milestone at BeaMed; On Track to File 510(k) Submission to FDA in Q2 2024 finance.yahoo.com - August 28 at 10:36 AM
	Pharma industry: Proposed ‘forever chemicals’ ban would stifle innovation, access to drugs euractiv.com - August 25 at 6:51 PM
	CSPC Innovation Pharmaceutical Co Ltd Class A (300765) uk.investing.com - August 2 at 4:46 AM
	Innovation Pharma updates on US patent applications covering use of Brilacidin in IBD, Coronaviruses & fungal diseases pharmabiz.com - June 24 at 8:50 AM
	Innovation Pharmaceuticals Provides Update on U.S. Patent Applications Covering Use of Brilacidin in Inflammatory Bowel Diseases, Coronaviruses and Fungal Diseases finance.yahoo.com - June 21 at 12:23 PM
	MIP Innovation Summit: UPC ready to take off despite initial caution managingip.com - June 8 at 8:19 AM
	Innovation Pharma Announces BeaMed Technologies Breakthrough in Development of Fiber Optic Probes for StingRay Laser System; Paves Way for Groundbreaking Integration Testing finance.yahoo.com - June 5 at 12:23 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

VIVO Cannabis

CVE:ABCN

ABcann Global Corporation manufactures and distributes medical cannabis. The company is headquartered in Napanee, Canada.

Abattis Bioceuticals

OTCMKTS:ATTBF

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.

Innovation Pharmaceuticals

OTCMKTS:IPIX

Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial